Characterization of a Mouse Model of Emphysema Induced by Multiple Instillations of Low-Dose Elastase by Milena V. Oliveira et al.
ORIGINAL RESEARCH
published: 07 October 2016
doi: 10.3389/fphys.2016.00457
Frontiers in Physiology | www.frontiersin.org 1 October 2016 | Volume 7 | Article 457
Edited by:
Yu Ru Kou,
National Yang-Ming University, Taiwan
Reviewed by:
Isaac Kirubakaran Sundar,
University of Rochester, USA
Hsin-Kuo Bruce Ko,
Taipei Veterans General Hospital,
Taiwan
*Correspondence:
Patricia R. M. Rocco
prmrocco@biof.ufrj.br
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Respiratory Physiology,
a section of the journal
Frontiers in Physiology
Received: 13 July 2016
Accepted: 22 September 2016
Published: 07 October 2016
Citation:
Oliveira MV, Abreu SC, Padilha GA,
Rocha NN, Maia LA, Takiya CM,
Xisto DG, Suki B, Silva PL and
Rocco PRM (2016) Characterization of
a Mouse Model of Emphysema
Induced by Multiple Instillations of
Low-Dose Elastase.
Front. Physiol. 7:457.
doi: 10.3389/fphys.2016.00457
Characterization of a Mouse Model
of Emphysema Induced by Multiple
Instillations of Low-Dose Elastase
Milena V. Oliveira 1 †, Soraia C. Abreu 1
†
, Gisele A. Padilha 1, Nazareth N. Rocha 1, 2,
Lígia A. Maia 1, Christina M. Takiya 3, Debora G. Xisto 1, Bela Suki 4, Pedro L. Silva 1 and
Patricia R. M. Rocco 1*†
1 Laboratory of Pulmonary Investigation, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de
Janeiro, Brazil, 2Department of Physiology and Pharmacology, Fluminense Federal University, Niteroi, Brazil, 3 Laboratory of
Cellular Pathology, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil,
4Department of Biomedical Engineering, Boston University, Boston, MA, USA
Many experimental models have been proposed to study the pathophysiological features
of emphysema, as well as to search for new therapeutic approaches for acute or
chronically injured lung parenchyma. We aimed to characterize an emphysema model
induced by multiple instillations of elastase by tracking changes in inflammation,
remodeling, and cardiac function after each instillation. Forty-eight C57BL/6 mice
were randomly assigned across two groups. Emphysema (ELA) animals received 1,
2, 3, or 4 intratracheal instillations of pancreatic porcine elastase (PPE, 0.2 IU) with a
1-week interval between them. Controls (C) received saline following the same protocol.
Before and after implementation of the protocol, animals underwent echocardiographic
analysis. After the first instillation of PPE, the percentage of mononuclear cells in
the lung parenchyma increased compared to C (p = 0.0001). The second instillation
resulted in hyperinflated alveoli, increased mean linear intercept, and reduced elastic
fiber content in lung parenchyma compared to C (p = 0.0197). Following the third
instillation, neutrophils and collagen fiber content in alveolar septa and airways increased,
whereas static lung elastance was reduced compared to C (p = 0.0094). After the
fourth instillation, the percentage of M1 macrophages in lungs; levels of interleukin-1β
(IL-1β), keratinocyte-derived chemokine, hepatocyte growth factor (HGF), and vascular
endothelial growth factor (VEGF); and collagen fiber content in the pulmonary vessel
wall were increased compared to C (p = 0.0096). At this time point, pulmonary arterial
hypertension was apparent, with increased diastolic right ventricular wall thickness. In
conclusion, the initial phase of emphysema was characterized by lung inflammation with
predominance of mononuclear cells, whereas at the late stage, impairment of pulmonary
and cardiovascular functions was observed. This model enables analysis of therapies
at different time points during controlled progression of emphysema. Accordingly, early
interventions could focus on the inflammatory process, while late interventions should
focus on restoring cardiorespiratory function.
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INTRODUCTION
Emphysema is a progressive disease characterized by airspace
enlargement, followed by a decline in lung function (Vestbo
et al., 1996). The pathogenesis of this disease is associated
with an imbalance between elastase and anti-elastase activity
(Janoff, 1985), rupture of alveolar walls (Suki et al., 2003),
inflammation in the airways and lung parenchyma (Snider, 1985;
Retamales et al., 2001), oxidative stress (MacNee, 2000), and
apoptosis (Demedts et al., 2006). However, emphysema does
not impair the lungs alone; it also produces extrapulmonary
effects that contribute to its severity and mortality (Agustí
et al., 2003; Fabbri et al., 2008). In this context, pulmonary
arterial hypertension, which results from destruction of capillary
vessel walls, may induce cor pulmonale, characterized by
right ventricular hypertrophy and failure (Smith and Wrobel,
2014).
Several experimental models have been proposed to reproduce
and explain the pathophysiology of emphysema, as well as to
test new therapies (Wright et al., 2008; Fricker et al., 2014;
Mercer et al., 2015; Vlahos and Bozinovski, 2015). Cigarette
smoke (CS) is the most common cause of emphysema and
has been used to evaluate cellular and molecular responses
(Yao et al., 2010, 2012). However, the CS model does not
reproduce the most severe, disabling aspects of the disease
seen in humans, and requires several months of exposure
(Churg and Wright, 2007), even though some groups have
adopted acute CS exposure protocols to identify mediators
and mechanisms involved in CS-induced inflammation (Mercer
et al., 2015). Conversely, in the elastase-induced emphysema
model, the disease develops rapidly after a single dose.
Additionally, the severity of emphysema induced by elastase
can be controlled according to enzyme dose (Snider et al.,
1986; Snider, 1992). Nevertheless, repeated doses of elastase
are required in order to develop systemic manifestations of
emphysema. Indeed, Lüthje et al. showed, in NMRI mice, that
multiple instillations of elastase caused weight loss, exercise
intolerance, diaphragmatic dysfunction, and cardiovascular
impairment (Lüthje et al., 2009). This model was adapted
by Cruz et al., who reported, in C57BL/6 mice, that four
instillations of elastase at 1-week intervals led to severe lung
damage characterized by inflammation and remodeling, in
addition to right ventricular dysfunction (Cruz et al., 2012). In
both studies, analyses occurred after all elastase instillations, by
which time the disease had progressed to the chronic stage.
However, the pathophysiological consequences of each elastase
administration during experimental emphysema development
remain unknown. A detailed characterization of emphysema
features after each elastase administration would lead to a better
understanding of the multiple dose elastase-induced emphysema
model.
Within this context, the aim of this study was to characterize
a model of emphysema induced by multiple instillations of
elastase through repeated analyses of pulmonary inflammatory
and remodeling processes, as well as of cardiorespiratory
function.
MATERIALS AND METHODS
This study was approved by the Ethics Committee of the Health
Sciences Centre, Federal University of Rio de Janeiro (CEUA-
019). All animals received humane care in compliance with
the “Principles of Laboratory Animal Care” formulated by the
National Society for Medical Research and the U.S. National
Research Council “Guide for the Care and Use of Laboratory
Animals.” The present study followed the ARRIVE guidelines for
reporting of animal research. Animals were housed in standard
laboratory cages (12-h light/12-h dark cycles at a temperature of
23± 1◦C), each one containing groups of three individuals. Mice
had access to food and water ad libitum.
Animal Preparation and Experimental
Protocol
Forty-eight female C57BL/6 mice (weight: 20–25 g, 2 months)
were randomly assigned using closed sealed envelopes into two
main groups: control (C) and emphysema (ELA). In the ELA
group, animals were subdivided to receive a single intratracheal
instillation of pancreatic porcine elastase [PPE (Sigma Chemical
Co., St Louis, MO, USA) 0.2 IU in 50 µL saline—ELA1], two
instillations with a 1-week interval (total dose, 0.4 IU PPE—
ELA2), three instillations at 1-week intervals (total dose, 0.6 IU
PPE—ELA3), and four instillations at 1-week intervals (total
dose, 0.8 IU PPE—ELA4). C groups received saline (50µL) using
the same protocol (Figure 1). For all intratracheal instillations,
which occurred in the laboratory between 9 and 12 a.m., mice
were anesthetized with inhaled sevoflurane 2% (Sevorane R©,
Cristália, Itapira, SP, Brazil). A midline cervical incision (1 cm)
was made to expose the trachea, and saline or PPE were instilled
using a bent 27-gauge tuberculin needle. The cervical incision
was closed with 5-0 silk suture, and the mice returned to their
cages.
Echocardiography
Twenty-four hours before the first instillation (INITIAL) and 24
h before euthanasia (FINAL), C and ELA animals underwent
echocardiographic analysis. For echocardiographic assessment
of cardiac function, the animals were anesthetized with inhaled
sevoflurane 2%, shaved over the precordial region, and examined
with a Vevo 770 system (VisualSonics, Toronto, ON, Canada)
coupled to a 30-MHz transducer. Images were obtained from
the parasternal, short-axis, and long-axis views. B-dimensional
parasternal short axis views of both ventricles were acquired
at the level of the papillary muscles to obtain left and right
ventricular areas (Lang et al., 2006). M-mode images from the
right outflow tract were obtained to evaluate right ventricular
wall thickness. Pulsed-wave Doppler was used to measure
pulmonary artery acceleration time (PAT), pulmonary artery
ejection time (PET), and the PAT/PET ratio, an indirect index
of pulmonary arterial hypertension (Thibault et al., 2010; Abbas
et al., 2013). All parameters followed American Society of
Echocardiography and European Association of Cardiovascular
Imaging recommendations (Lang et al., 2015).
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FIGURE 1 | Schematic flow chart (A) and timeline of study design (B). C group, control (animals that received 1, 2, 3, or 4 intratracheal instillations of saline at
1-week intervals). ELA1, single intratracheal instillation of pancreatic porcine elastase (PPE). ELA2, two instillations of PPE given 1 week apart. ELA3, three instillations
of PPE at 1-week intervals. ELA4, four instillations of PPE at 1-week intervals.
Mechanical Parameters
One week after the last instillation, the animals were
premedicated with diazepam 10 mg/kg i.p. (Compaz R©,
Cristália, Itapira, SP, Brazil) anesthetized with thiopental
sodium 20 mg/kg i.p. (Thiopentax R©, Cristália, Itapira, SP,
Brazil), tracheotomized, paralyzed with vecuronium bromide
0.005 mg/kg i.v. (Vecuron R©, Cristália, Itapira, SP, Brazil),
and ventilated with a constant flow ventilator (Samay VR15;
Universidad de la Republica, Montevideo, Uruguay) using the
following settings: rate 100 breaths/min, tidal volume (VT) 0.2
mL, and fraction of inspired oxygen (FiO2) 0.21. The anterior
chest wall was surgically removed and a positive end-expiratory
pressure of 2 cm H2O applied. Airflow and tracheal pressure
(Ptr) were measured. Lung mechanics were analyzed by the
end-inflation occlusion method. In an open chest preparation,
Ptr reflects transpulmonary pressure (PL). Static lung elastance
(Est,L) was determined by dividing lung elastic recoil pressure
(Pel) by VT. Est,L was measured 10 times in each animal. All data
were analyzed using ANADAT software (RHT-InfoData, Inc.,
Montreal, Quebec, Canada). All experiments lasted <15 min.
Lung Histology
At the end of the experiment, laparotomy was performed and
1000IU of heparin (Hemofol R©, Cristália, Itapira, SP, Brazil)
was injected into the vena cava. The trachea was clamped
at end-expiration, and the abdominal aorta and vena cava
were sectioned, producing massive hemorrhage and terminal
bleeding for euthanasia. The left lung was then removed, fixed
in 3% buffered formalin, and embedded in paraffin; 4-µm
thick slices were cut and stained with hematoxylin–eosin. Lung
histology analysis was performed with an integrating eyepiece
with a coherent system consisting of a grid with 100 points
and 50 lines of known length coupled to a conventional light
microscope (Olympus BX51, Olympus Latin America Inc.,
Brazil). The volume fraction of hyperinflated, collapsed, and
normal pulmonary areas, the mean linear intercept (Lm), and the
percentage of neutrophils in pulmonary tissue were determined
by the point-counting technique across 10–20 random, non-
overlapping microscopic fields at 200X, 400X, and 1000X
magnification, respectively (Weibel, 1990; Hsia et al., 2010). In
addition, inflammatory changes in the airway and pulmonary
vessel wall were evaluated in a blinded fashion. The total number
of cells was graded on a scale of 0–4, with 0 = absent; 1 = slight;
2=mild; 3=moderate; and 4= severe.
The amount of collagen fibers (stained by the Picrosirius
polarization method) was computed in alveolar septa, small
airways, and pulmonary vessel walls. Elastic fiber content was
computed in alveolar septa using Weigert’s resorcin fuchsin
method with oxidation. The images were generated by a
microscope (Axioplan, Zeiss) connected to a digital camera
(Sony Trinitron CCD, Sony, Tokyo, Japan) and fed into a
computer through a frame grabber (Oculus TCX, Coreco, St.
Laurent, QC, Canada) for oﬄine processing. The thresholds for
collagen and elastic fibers were established after enhancement
Frontiers in Physiology | www.frontiersin.org 3 October 2016 | Volume 7 | Article 457
Oliveira et al. Characterization of a Mouse Emphysema Model
TABLE 1 | Lung mechanics, morphometry, and inflammatory cells.
C ELA1 ELA2 ELA3 ELA4
Static lung elastance (cmH2O/mL) 35.9± 2.8 33.7± 2.9 29.5± 3.5 25.5± 2.8*
,** 24.5± 2.4*,**
Normal (%) 99.7± 1.5 97.7± 1.0 81.2± 3.5*,** 64.7± 2.7*,**# 51.8± 3.8*,**,#,†
Collapse (%) 0.3± 1.5 2.3± 1.0 6.5± 1.7*,** 12.5± 0.7*,**# 17.2± 3.2*,**,#,†
Hyperinflation (%) 0.0± 0.0 0.0± 0.0 12.2± 2.6*,** 22.6± 2.1*,**# 30.9± 1.8*,**,#,†
Mononuclear cells (%) 31.0± 1.1 35.2± 0.5* 37.1± 1.2* 41.8± 1.5*,**# 46.2± 2.5*,**,#,†
Neutrophils (%) 1.4± 0.3 1.6± 0.3 2.0± 0.8 3.8± 1.7* 5.2± 1.5*,**,#
Inflammation score, airway 0 (0–1) 0.5 (0–1) 1 (0–2) 2.5 (2–3)* 3.5 (3–4)*,**,#
Inflammation score, pulmonary vessel wall 0.5 (0–1) 1 (0–1) 1 (1–2) 1.5 (1–2) 4 (2.75–4)*,**
Fractional area of normal alveoli, collapsed alveoli, lung hyperinflation, mononuclear cells, neutrophils and airway and pulmonary vessel wall inflammation scores. C group, control
(animals that received 1, 2, 3, or 4 intratracheal instillations of saline at 1-week intervals). ELA1, single intratracheal instillation of pancreatic porcine elastase (PPE). ELA2, two instillations
of PPE given 1 week apart. ELA3, three instillations of PPE at 1-week intervals. ELA4, four instillations of PPE at 1-week intervals. Values are means ± SD of six animals in each ELA
group and six animals in C group. For the inflammation score, values are median (interquartile range) of six animals in each ELA group and six animals in C group. *Significantly different
from C group (p < 0.05). **Significantly different from ELA1 group (p < 0.05). #Significantly different from ELA2 group (p < 0.05).
†
Significantly different from ELA3 group (p < 0.05).
FIGURE 2 | Mean linear intercept (A) and representative photomicrographs of lung parenchyma stained with hematoxylin–eosin (H&E) (B). C group,
control (animals that received 1, 2, 3, or 4 intratracheal instillations of saline at 1-week intervals). ELA1, single intratracheal instillation of pancreatic porcine elastase
(PPE). ELA2, two instillations of PPE given 1 week apart. ELA3, three instillations of PPE at 1-week intervals. ELA4, four instillations of PPE at 1-week intervals. Values
are means + SD of six animals in each group. *Significantly different from C group (p < 0.05). **Significantly different from ELA1 group (p < 0.05). #Significantly
different from ELA2 group (p < 0.05). †Significantly different from ELA3 group (p < 0.05).
of contrast up to the point where the fiber was easily identified
as either birefringent (collagen) or black (elastic) bands at
400X magnification using Image Pro Plus 7.1 Software (Media
Cybernetics, Silver Spring,MD, USA; Fullmer et al., 1974; Padilha
et al., 2015; Henriques et al., 2016). The areas occupied by the
elastic and collagen fibers were measured by digital densitometric
recognition, divided by the tissue area of each zone of interest,
and expressed as the percentage of elastic or collagen fiber in the
alveolar septa, airways, or pulmonary vessel wall.
Immunohistochemistry
Immunohistochemistry for macrophage subpopulations (M1
and M2 phenotypes) in lung tissue was done using iNOS
rabbit anti-mouse polyclonal antibody (M1, catalog no.
Rb-9242, Thermo Scientific) and arginase-1 rabbit anti-mouse
polyclonal antibody (M2, catalog no. sc-20150, Santa Cruz
Biotechnology). Antibodies were detected using a secondary
antibody labeled with peroxidase (Histofine mouse MAX PO
anti-rat and antirabbit, Nichirei Biosciences, Tokyo, Japan)
followed by the chromogen substrate diaminobenzidine
(Liquid DAB, Dakocytomation, USA, catalog no. K3468).
Analysis was performed in 30 images of high-power fields
(400X magnification) per slide, taken with an Evolution
VR Cooled Color 13-bit digital camera (Media Cybernetics,
Canada) and manually selected under a light microscope
(Nikon Eclipse 400, Nikon Instruments Tokyo, Japan).
The areas occupied by nucleated macrophages and cells
with positive staining for the phenotype marker in each
tissue were then calculated and expressed as fractional area
occupied by positive cells. The images were analyzed using
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Image Pro Plus 7.1 (Media Cybernetics, Silver Spring, MD,
USA).
Enzyme-Linked Immunosorbent Assay
(ELISA)
Levels of keratinocyte-derived chemokine (KC, amouse analog of
interleukin-8), interleukin-1β (IL-1β), hepatocyte growth factor
(HGF), and vascular endothelial growth factor (VEGF) in lung
tissue were evaluated by ELISA using matched antibody pairs
from PeproTech and R&D Systems (Minneapolis, MN, USA),
according to manufacturer instructions. Results are expressed as
pg/mL.
Statistical Analysis
The number of animals in each group was based on a previous
study conducted in our laboratory (Cruz et al., 2012). A sample
size of six animals per group would provide the appropriate
power (1 − β = 0.8) to identify significant (α = 0.05) differences
in mean linear intercept between C and ELA groups, taking into
account an effect size d = 1.97, a two-sided test, and a sample
size ratio = 1 (G ∗- Power 3.1.9.2, University of Düsseldorf,
Germany).
Normality and equality of variances were tested by the
Kolmogorov–Smirnov test with Lilliefors correction and Levene’s
test, respectively. Parametric data were expressed as mean
(SD) and non-parametric data as median (interquartile range).
One-way ANOVA followed by Tukey’s test was used to
compare parametric data. A paired t-test was used to compare
echocardiography parameters between INITIAL and FINAL
at each time point. Statistical significance was established as
p < 0.05. All tests were performed in the GraphPad Prism
v6.07 statistical software package (GraphPad Software, La Jolla,
California, USA).
RESULTS
Since no major differences were observed among the C groups at
different time points, a single pooled control group was used to
represent them.
Lung Mechanics
Static lung elastance was lower in ELA3 and ELA4 compared to
the C (p= 0.0094 and 0.0038, respectively) and ELA1 (p= 0.0098
and 0.0028, respectively) groups (Table 1).
Lung Morphometry
Mean linear intercept (Figure 2), fractional area of alveolar
collapse, and hyperinflated alveoli (Table 1) increased in ELA2
compared to the C (p = 0.0039, 0.0017, 0.0002, respectively) and
ELA1 groups (p < 0.0001, p= 0.0042, 0.0002, respectively).
Elastic Fiber Content
The degree of elastolysis was evaluated by quantification of elastic
fibers. Elastic fiber content decreased in ELA2 compared to the C
and ELA1 groups (p= 0.0197 and 0.0132, respectively; Figure 3).
Fibrosis in Alveolar Septa, Airways, and
Pulmonary Vessel Wall
Collagen fiber content in alveolar septa was higher in ELA3
and ELA4 compared to the C (p = 0.0009 and p < 0.0001,
respectively), ELA1 (p = 0.0002 and p < 0.0001, respectively),
FIGURE 3 | Elastic fiber content in alveolar septa (A) and representative photomicrographs of lung parenchyma stained with Weigert’s resorcin
fuchsin method with oxidation (elastic fibers) (B). Arrows: Elastic fibers (stained black). C group, control (animals that received 1, 2, 3, or 4 intratracheal
instillations of saline at 1-week intervals). ELA1, single intratracheal instillation of pancreatic porcine elastase (PPE). ELA2, two instillations of PPE given 1 week apart.
ELA3, three instillations of PPE at 1-week intervals. ELA4, four instillations of PPE at 1-week intervals. Values are means + SD of six animals in each group.
*Significantly different from C group (p < 0.05). **Significantly different from ELA1 group (p < 0.05). #Significantly different from ELA2 group (p < 0.05). †Significantly
different from ELA3 group (p < 0.05).
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and ELA 2 (p = 0.0010 and p < 0.0002, respectively) groups.
Additionally, the amount of collagen fiber in alveolar septa was
higher in ELA4 than ELA3 (p = 0.0003; Figure 4A). In the
airways, collagen fiber content was higher in ELA3 than in C
(p = 0.0118) and ELA1 (p = 0.0015; Figure 4B). Collagen fiber
content in the pulmonary vessel wall was higher in ELA4 than
in the C and ELA1 groups (p = 0.0096 and 0.0034, respectively;
Figure 4C).
Correlations between Lung Morphometry,
Static Lung Elastance, and Collagen and
Elastic Fiber Content
Interestingly, there was a correlation between increase in mean
linear intercept and elastolysis (p < 0.0001), as well as with
worsening of lung function (p < 0.0001; Figures S1A,B). There
was also a strong correlation between increased deposition of
collagen fibers and the increase in mean linear intercept (p <
0.001; Figure S1C).
Lung Inflammation
Lung inflammation was evaluated by measuring the fractional
area of total cells as well as mononuclear cells and neutrophils
in alveolar septa. Mononuclear cells increased in the lung
parenchyma in ELA1 compared to C (p = 0.0001), while the
percentage of neutrophils in lung tissue was higher in ELA3 than
in controls (p= 0.0157; Table 1).
Alveolar macrophages play a crucial role in the pathogenesis
of emphysema. They can be activated by a variety of extracellular
signals to polarize into M1 macrophages (associated with
antimicrobial response and inflammation) or M2 macrophages
(associated with wound healing and resolution of inflammation).
For a more in-depth analysis of lung inflammation, the
M1 (iNOS-positive cells) and M2 (arginase-1-positive cells)
subpopulations were quantified in this study. The M1
macrophage percentage was higher in ELA4 than C, ELA1,
and ELA2 groups (p = 0.0014, 0.0036, 0.0005, respectively;
Figure 5A). No significant difference was observed in the
number of M2 macrophages between C and ELA groups,
regardless of the time point of analysis (Figure 5B).
Additionally, the total number of inflammatory cells in the
airway was increased in ELA3 compared to C and in ELA4
compared to the C, ELA1, and ELA2 groups. In the pulmonary
vessel wall, the total number of inflammatory cells was higher in
ELA4 compared to C and ELA1 animals (Table 1).
Pro-inflammatory and Pro-fibrogenic
Mediators in Lung Tissue
Pro-inflammatory (KC and IL-1β and pro-fibrogenic (HGF and
VEGF) mediators were measured in lung tissue. The KC level
FIGURE 4 | Collagen fiber content and representative photomicrographs of alveolar septa (A), airways (B), and pulmonary vessel wall (C) stained with
the Picrosirius-polarization method. C group, control (animals that received 1, 2, 3, or 4 intratracheal instillations of saline at 1-week intervals). ELA1, single
intratracheal instillation of pancreatic porcine elastase (PPE). ELA2, two instillations of PPE given 1 week apart. ELA3, three instillations of PPE at 1-week intervals.
ELA4, four instillations of PPE at 1-week intervals. Values are means + SD of six animals in each group. *Significantly different from C group (p < 0.05). **Significantly
different from ELA1 group (p < 0.05). #Significantly different from ELA2 group (p < 0.05). †Significantly different from ELA3 group (p < 0.05).
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FIGURE 5 | Immunohistochemistry for iNOS (A) and arginase-1 (B). Note positive cells stained brown (arrows). C group, control (animals that received 1, 2, 3, or
4 intratracheal instillations of saline at 1-week intervals). ELA1, single intratracheal instillation of pancreatic porcine elastase (PPE). ELA2, two instillations of PPE given
1 week apart. ELA3, three instillations of PPE at 1-week intervals. ELA4, four instillations of PPE at 1-week intervals. Values are shown as box-plots (median,
interquartile range, minimum, and maximum) of six animals in each group. *Significantly different from C group (p < 0.05). **Significantly different from ELA1 group (p
< 0.05). #Significantly different from ELA2 group (p < 0.05).
was higher in ELA4 than C (p = 0.0012), whereas the IL-1β level
was increased in ELA4 compared to the C and ELA2 groups (p
= 0.0094, 0.0148, respectively). HGF level was higher in ELA4
compared to the C, ELA1, and ELA2 groups (p= 0.0321, 0.0345,
0.0242, respectively), and VEGF level was increased in ELA4
compared to the C, ELA1, ELA2, and ELA3 groups (p = 0.0015,
0.0026, 0.0010, 0.0018, respectively; Figure 6).
Cardiac Function
Cardiac function was evaluated using echocardiography. In
ELA4, right ventricular end-diastolic area and diastolic right
ventricular wall thickness were higher in FINAL compared to
INITIAL (p = 0.0038 and 0.0025, respectively). Additionally,
in FINAL, ELA4 animals exhibited increased right ventricular
end-diastolic area compared to ELA1, ELA2, and ELA3 animals
(p = 0.0115, 0.0325, 0.0106, respectively), as well as increased
diastolic right ventricular wall thickness compared to the ELA1
and ELA3 groups (p = 0.0367, 0.0127, respectively). PAT/PET
ratio was lower in FINAL than INITIAL in ELA4 (p = 0.0025).
In FINAL, PAT/PET ratio was reduced further in ELA4 than
in ELA1 and ELA3 (p = 0.0008 and 0.0381, respectively;
Figure 7).
DISCUSSION
In the present study, we observed that: (1) the first instillation
of PPE yielded an increased percentage of mononuclear cells
in the lung parenchyma; (2) the second instillation resulted
in hyperinflated alveoli, increased mean linear intercept, and
reduced elastic fiber content in lung parenchyma; (3) the third
instillation led to increased neutrophils and collagen fiber content
in alveolar septa and airways, whereas static lung elastance was
reduced; and (4) the fourth instillation yielded an increase in
percentage of M1macrophages in the lung, increased levels of IL-
1β, KGF, HGF, and VEGF, and increased collagen fiber content
in the pulmonary vessel wall. At this time point, pulmonary
arterial hypertension, characterized by a reduced PAT/PET ratio,
was present, with increased diastolic right ventricular wall
thickness and right ventricular end-diastolic area. We have thus
demonstrated that the currentmultiple elastase instillationmodel
had a cumulative effect, starting with a mild inflammatory
process followed by increased lung inflammation and changes
in inflammatory cell profile, elastolysis, fibrosis in alveolar septa,
airway, and pulmonary vessel wall, as well as cardiorespiratory
functional impairment. Of particular note is the finding that,
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FIGURE 6 | Levels of keratinocyte-derived chemokine (KC, a mouse analog of interleukin-8) (A), interleukin (IL)-1β (B), hepatocyte growth factor (HGF)
(C), and vascular endothelial growth factor (VEGF) (D) in lung tissue. C group, control (animals that received 1, 2, 3, or 4 intratracheal instillations of saline at
1-week intervals). ELA1, single intratracheal instillation of pancreatic porcine elastase (PPE). ELA2, two instillations of PPE given 1 week apart. ELA3, three instillations
of PPE at 1-week intervals. ELA4, four instillations of PPE at 1-week intervals. Values are shown as box-plots (median, interquartile range, minimum, and maximum) of
six animals in each group. *Significantly different from C group (p < 0.05). **Significantly different from ELA1 group (p < 0.05). #Significantly different from ELA2 group
(p < 0.05). †Significantly different from ELA3 group (p < 0.05).
following the initial inflammation, airspace enlargement (a
hallmark of emphysema) occurred simultaneously with loss of
elastic fibers at week 2, whereas cardiopulmonary complications
happened together with the appearance of collagen in the
pulmonary vasculature.
Elastase has been widely used to induce emphysema in
animals (Cruz et al., 2012; Craig et al., 2013; Kobayashi
et al., 2013; Sandhaus and Turino, 2013; Antunes et al., 2014).
However, lung morphological and functional changes have been
usually evaluated at only one time point, which has hindered
understanding of the full pathophysiology of this model. To our
knowledge, this was the first study to evaluate the cumulative
effect of elastase instillation on cardiorespiratory parameters.
After the first elastase instillation, a mild increase in
mononuclear cells was observed, without lung damage or release
of pro-inflammatory mediators and growth factors. Neutrophil
infiltration and the increase in M1 macrophage percentage were
present after the fourth elastase instillation, as were increased
levels of KC and IL1-β. These changes may be associated with
the presence of elastolysis, which was most intense at this time
point (when the elastic fiber content reduced around 62%).
In this context, elastin fragments act as chemoattractants for
recruitment of macrophages and neutrophils (Houghton et al.,
2006). Moreover, the elastolytic process occurs due to increased
activity of neutrophils and macrophages, which release matrix
metalloproteases, thus promoting elastic fiber rupture (Churg
et al., 2012). After the second instillation of elastase, elastic fiber
content was reduced even without neutrophil infiltration. We
speculate that this loss of elastic fibers is associated with an
increase in mononuclear cells releasing matrix metalloproteases
(MMP), mainly MMP9, which has greater elastolytic capacity
(Russell et al., 2002).
The mean linear intercept also increased with elastase
instillations. This is consistent with previous studies that reported
the development of structural changes after instillation of elastase
(O’Donnell et al., 1999; Ito et al., 2004; Cheng et al., 2009;
Hamakawa et al., 2011; Szabari et al., 2012).
Emphysema is characterized by changes in the organization
and composition of extracellular matrix (Ito et al., 2005; Suki
et al., 2012; Szabari et al., 2012; Takahashi et al., 2014; Robertoni
et al., 2015). In an attempt to repair the damaged lung, new
collagen fibers are resynthesized, but are relatively weak, and,
because they can rupture, tend to reduce overall tissue stiffness
and static lung elastance (Suki et al., 2003). Similarly, Ito et al.
reported that increased total collagen fibers, including types I
and III, led to an increase in compliance 21 days after elastase
administration (Ito et al., 2005). A possible explanation for this
apparent paradox is that the remodeling process assumes an
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FIGURE 7 | Pulmonary artery acceleration time/pulmonary artery ejection time (PAT/PET) ratio (A), right ventricular end-diastolic area (B), diastolic
right ventricular wall thickness (C), and short-axis B-dimensional views of both ventricles in ELA4 animals (D). LV, left ventricle; RV, right ventricle; INITIAL,
before instillation of saline or PPE; FINAL, after instillation of saline or PPE. Values are means + SD of six animals in each group. *Significantly different from C group (p
< 0.05). **Significantly different from ELA1-FINAL group (p < 0.05). #Significantly different from ELA2-FINAL group (p < 0.05). †Significantly different from
ELA3-FINAL group (p < 0.05).
abnormal character in emphysema, promoting the formation of
weaker and disorganized collagen fibers (Hamakawa et al., 2011).
In the present study, we observed a time lag between elastic fiber
deterioration and collagen deposition. This could be explained by
the fibroblasts, which are in a quiescent state during equilibrium.
However, after injury, in an attempt to restore homeostasis,
these cells become activated and convert into myofibroblasts
(Stenmark et al., 2002), thus secreting collagen fibers (Wynn and
Ramalingam, 2012).
Degradation of elastic fibers and remodeling of collagen allow
rupture of septal walls, which, in this study, was most evident
after the third and fourth instillations of elastase. This led to loss
of elastic recoil and functional changes, which is consistent with
other studies (Ito et al., 2005; Hantos et al., 2008; Hamakawa et al.,
2011; Szabari et al., 2012).
HGF was increased only after the fourth instillation. In
the lungs, HGF is produced by fibroblasts, and it stimulates
epithelial cell proliferation after lung damage (Ohmichi et al.,
1996; Sakamaki et al., 2002). Previous studies have shown
that HGF levels increase 1 week after administration of a
single dose of elastase (Shigemura et al., 2005). In addition,
pulmonary endothelial cells are injured in emphysema, and can
be the main source of VEGF. This growth factor is crucial for
pulmonary vessel formation and development (Shalaby et al.,
1995; Ferrara et al., 1996). Previous studies have shown that
VEGF levels are reduced in emphysema models, suggesting
endothelial cell injury (Kasahara et al., 2001; Cruz et al., 2012;
Girón-Martínez et al., 2014). In contrast, in the present study,
we observed an increase in VEGF in ELA4. We hypothesized
that, with increased elastase administration, lung endothelial
cells did indeed sustain more damage, but, since there are
around 800 to 1000 capillaries for each alveolus (West, 2013),
the remaining (undamaged) functional endothelial cells could
increase VEGF levels. Additionally, we cannot rule out the
possibility of crosstalk between HGF and VEGF (Cooper, 1992;
Ferrara, 2004), whereby higher levels of HGF might increase
VEGF synthesis.
Cardiovascular impairment was observed only after the
fourth instillation, and was due to pulmonary damage. Previous
studies have shown that the PAT/PET ratio is an important
indirect indicator of pulmonary arterial hypertension (Beard
et al., 1991; Jones et al., 2002; Thibault et al., 2010). In our
study, the reduction in PAT/PET ratio can be attributed to
increased collagen fiber content in lung vessels, which is in
line with a previous study (Schreier et al., 2013). Together with
vascular remodeling, arterial pulmonary hypertension can also be
caused by hypoxic pulmonary vasoconstriction (Siebenmann and
Lundby, 2015). This increased afterload induced morphological
changes in the right ventricle, including in its area and wall
thickness. Such changes characterize cor pulmonale, one of the
main conditions that lead to death in patients with emphysema
(Kawut et al., 2014).
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This study has some limitations. First, no animal model is
expected to reproduce all features of emphysema as it occurs
in humans, since the natural history of the condition is not
observed in non-human animals, and the various comorbidities
that are often observed in humans are also absent in animals.
Each choice of animalmodel has its own benefits and deficiencies.
Nevertheless, there is a great need to develop animal models
closely resembling various aspects of human emphysema to test
different drugs and therapies that might reduce inflammation
and improve lung repair. Therefore, a better understanding of
the morphological and functional changes that occur during
the course of our model of emphysema will enable us to
test therapies early and late in the course of this disease.
Second, each intratracheal administration contained 0.2 IU of
PPE, which could be considered a low dose compared to
those used in previous studies. To clarify whether a single
0.8-IU dose of PPE would result in similar effects, additional
experiments were performed in 10 animals, but all died 3
days after instillation. Third, analysis of the degradation and
remodeling of extracellular matrix components was focused on
collagen and elastic fiber content, and not on organization of
other components. Fourth, only female mice were included
in the sample. This was a deliberate choice based on the
previous work of Cruz et al. (2012), in which female mice
were used to localize the site of bone marrow injections whose
cells were derived from male mice. Further studies using both
female and male animals are needed to elucidate whether
sex-specific responses to the elastase model exist. Finally, the
current model was not compared with other models of CS-
induced or elastase-induced emphysema, since our aim was to
evaluate the temporal evolution of pulmonary inflammatory,
airway remodeling, and cardiorespiratory function in a model
of emphysema induced by multiple instillations of low-dose
elastase.
In conclusion, the initial phase of elastase-induced
emphysema inmice was characterized by lung inflammation with
predominance of mononuclear cells, whereas at the late stage,
impairment of pulmonary and cardiovascular functions was
observed. This model enables analysis of therapies at different
time points during the clinical course of emphysema. Given our
findings, we suggest that early interventions for emphysema
management could focus on the inflammatory process, while
late interventions should focus on restoring cardiorespiratory
function.
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